Apellis Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/29/21
Apellis Reiterates Plans to Submit a New Drug Application in the First Half of 2022 for Pegcetacoplan for Geographic Atrophy Following FDA FeedbackGlobeNewsWire • 11/12/21
Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
Apellis to Present New Data Reinforcing EMPAVELI™ (pegcetacoplan) Efficacy and Safety in Patients with PNH at the 2021 ASH Annual MeetingGlobeNewsWire • 11/04/21
Apellis Pharmaceuticals to Host Conference Call on November 8, 2021 to Discuss Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/01/21
Apellis (APLS) Gets CHMP Nod for Rare Blood Disorder Drug (Revised)Zacks Investment Research • 10/21/21
Apellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of PNHGlobeNewsWire • 10/15/21
Apellis Announces Detailed Results from Phase 3 DERBY and OAKS Studies Presented at Retina Society Annual MeetingGlobeNewsWire • 09/30/21
Apellis Pharmaceuticals to Present at the 2021 Cantor Virtual Global Healthcare ConferenceGlobeNewsWire • 09/20/21
APLS Stock: The Trial Results That Have Apellis Pharmaceuticals Plunging TodayInvestorPlace • 09/10/21
Apellis Pharmaceuticals stock plunges after disappointing result from GA treatment studiesMarket Watch • 09/10/21
Apellis Unveils Mixed Results For Eye Disorder Drug, But Still Hopes To Pass FDA Finish LineBenzinga • 09/10/21
Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022GlobeNewsWire • 09/09/21
Apellis Pharmaceuticals, Inc. (APLS) Down 6.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/08/21
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to New VP, Corporate Controller / Chief Accounting OfficerGlobeNewsWire • 09/03/21
Thursday Afternoon Analyst Upgrades and Downgrades: Apple, AutoDesk and More24/7 Wall Street • 08/19/21